Keyphrases
Prostate Cancer
100%
C-X-C Chemokine Receptor Type 4 (CXCR4)
100%
Antitumor Effect
100%
Common Cancers
23%
Tumor Cells
15%
CXCR4/CXCL12 Axis
15%
Apoptosis Inhibition
15%
TRAIL-induced Apoptosis
15%
Cancer Mortality
15%
Combination Therapy
7%
Clinical Application
7%
Cancer Types
7%
Cancer Development
7%
Data Reporting
7%
Cancer Research
7%
Tumor Cell Proliferation
7%
Angiogenesis
7%
Chemotherapy
7%
Tumor Recurrence
7%
High Proportion
7%
Cytotoxic Drugs
7%
Tumor Metastasis
7%
Cancer Therapeutics
7%
Prostate Tumor Cells
7%
Apoptosis
7%
Primary Tumor Growth
7%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
7%
Conventional Therapy
7%
Systemic Toxicity
7%
Effective Approach
7%
Induced Effect
7%
Cancer Metastasis
7%
5-year Survival
7%
Apoptotic Effect
7%
Chemotherapy Failure
7%
Transformed Cells
7%
Contradictory Data
7%
Antitumor
7%
Drug Sensitivity
7%
Resistant Cells
7%
Cancer Causes
7%
Drug Resistance
7%
Oman
7%
INIS
cancer
100%
prostate
100%
sensitivity
100%
tumors
100%
apoptosis
28%
drugs
19%
tumor cells
14%
metastases
9%
therapy
9%
males
9%
chemotherapy
9%
growth
9%
death
9%
Medicine and Dentistry
Prostate Cancer
100%
Neoplasm
100%
Programmed Cell Death
38%
Malignant Neoplasm
38%
Tumor Cell
23%
Metastatic Carcinoma
15%
Chemotherapy
7%
Angiogenesis
7%
Cancer Mortality
7%
Combination Therapy
7%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
7%
Tumor Recurrence
7%
Drug Therapy
7%
Cytotoxic Agent
7%
Cell Proliferation
7%
Survival Rate
7%
Cancer Growth
7%
Prostate Tumor
7%
Metastasis Potential
7%
Transformed Cell
7%
Cancer Types
7%
Cancer Research
7%
Primary Tumor
7%
Tumor Progression
7%
Drug Resistance
7%